CARY, North Carolina (October 10, 2025) - FMC and Atticus have settled their dispute over Chlorantraniliprole ('CTPR'), resulting in Atticus's withdrawal of its declaratory judgment action against FMC. With the settlement, Atticus plans to enter the CTPR market beginning December 7, 2025. "We are pleased to arrive at this professional and respectful outcome that advances a superior chemistry through its full product life cycle and agronomic potential," states Randy Canady, CEO, Atticus.